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Abstract
I. Selective chlorination and fluorination of quinols
II. Synthetic study of strongylophorine-26
by
Sihan Li
Advisor: Dr. Shengping Zheng
Organic compounds containing halogen are an important and useful class of intermediates that
can be converted to other functionalities. This thesis describes our strategy in selective
chlorination and fluorination of quinols to offer the corresponding aromatic structures. Quinols,
or cyclohexadienones, as oxidized derivatives of phenols, have their remarkable chemical
reactivities, including additions to enone, enolate alkylations, aldol reactions, cycloadditions, and
rearrangements. Dienone-phenol rearrangement provides the asymmetric route since the
stereocenters located in the six-membered ring of various cyclohexadienone were widely using
in building larger chiral arrays for many total syntheses
Chapter one of this thesis discusses our new selective nucleophilic chlorination of quinol to
afford ortho- chloride phenol. This one-step selective chlorination can easily be performed using
readily available quinols and thionyl chloride. In Chapter two, inspired by chlorination strategy,
we develop a new fluorination strategy to offer fluorinated cyclohexadienone products by
deoxofluorination of quinols. Chapter three describes our study work on the total synthesis of
Strongylophorine-26. The difficulties we met and our solution is discussed.
v
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Chapter 1 Selective Synthesis of ortho-Chlorophenol by Quinol 
Nucleophilic Addition 
 
1.1 Selective Synthesis of ortho-Chlorophenol by Quinol Nucleophilic Addition 
1.1.1 Halogenation of Phenol 
Halogenation of aryl compounds is a classic and prominent topic in organic chemistry. Organic 
compounds containing halogen are an important and useful class of intermediates that can be 
converted to other functionalities through simple chemical transformation.1 The aryl halides, for 
instance, can serve as starting materials for organometallic reagents and are frequently used as 
precursors in pharmaceutical synthesis.2 Moreover, aryl halides and other halogen-containing 
compounds are frequently used in metal-catalyzed organometallic coupling. A well-known 
example is the Negishi Coupling, which allows the preparation of unsymmetrical biaryls by aryl 
halide in good yields.3 Aryl halides also feature in the Hiyama coupling, which uses palladium 
catalysts to form a new C-C bond,4 while the use of Grignard reagents with aryl halide in the 
Kumada coupling enabled biaryl formation.5 Furthermore, aryl halides, along with aryl carboxylic 
acid, aryl boronic acids, and aryl diazonium salts are considered as limited aryl radical sources.6 
Due to the versatility of aryl halides, their synthesis is still viewed as a popular topic. 
For aryl halide synthesis, phenol is often used as a precursor. Because phenols are highly 
reactive to aromatic substitution, they are a good source of bulk complex compounds. However, 
isomerism during the substitution reaction is hard to control.7 Halogenation of phenol usually 
cannot stop in one substitution. Phenol with bromine water can directly form white precipitate 
2,4,6-tribromophenol. In the past decade, hundreds of different methods have emerged to guide 
selective halogenation of aromatic compounds and more than 70 phenol chlorination protocols.8 
There are still two main challenges chemists face during halogenation of phenols: selectivity and 
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higher yields in mild conditions. NCS and H2SO4, first attempted in 1965, is the oldest selective 
method for forming chlorination phenol, yet harsh conditions limit its wider use. Cl2 and silica 
offered by Kiji is in mild condition and high yield, but some products are para-/ortho isomers 
mixtures.10 Also, HCl can be used as a chlorinating reagent, and Bedekar reports HCl/H2O2 
halogenation and the oxidation system can form chlorophenol.11 Under halogenation and 
oxidation conditions, t-BuOCl are also used to produce chlorophenol.12 With all these methods 
available, controlling selectivity is still an important challenge for every chemist. 
 
1.1.2 Green Chemistry in the chlorination of phenols 
  During the last decade, environmental pollution in the synthesis kept drawing people’s attention, 
green chemistry for halogenation already became the most popular research topic. The traditional 
chlorination processes, which use many high toxic and biological hazard chlorination reagents and 
produce many side products, are opposite to the principles of green chemistry. Basing on 
principles of green chemistry, the design of new chlorination of phenols method asks less 
hazardous reagent to achieve good selectivity and/or generate minimal waste or by‐products is our 
new challenge.13 
Chandalia’s oxidative halogenation strategy 
  Oxidative halogenation has found significant development in the preparation of organo-halogen 
compounds. HCl/H2O2 system can benefit from low-cost resources and avoid the use of highly 
toxic halogen reagents.  However, HCl is difficult to oxidative with dilute H2O2, and oxidative 
chlorination is achieved by using an excess of HCl at higher temperatures.14 Chandalia had 
reported one sample of oxidative chlorination of 4-methylphenol to give 2-chloro-4-methyl 










Pd-catalyzed C–H chlorination in the selective synthesis of 2-chlorophenols16  
  Since classic approaches to the synthesis of 2-chlorophenols generally lack site-selectivity and 
always provide a mixture of o- and p- isomers.17 Palladium-catalyzed C-H 
functionalization/halogenation has emerged as a particularly useful approach for producing 
halogenated aromatic products with the selectivity that normally could not be obtained under 
simple electrophilic halogenation conditions. Rao reported an example of a one spot synthesis of 
valuable 2-chloro/bromophenols through a room temperature, carbamate-directed, 
palladium-catalyzed. Their method based on 1) under certain acidic condition, palladium catalysts 
could promote C-H activation via an orthometalation process through weak coordination with the 
carbonyl oxygen of phenol esters, carbonates or carbamates;18 2) a potential subsequent C-Cl bond 
formation via the reductive elimination could afford the corresponding 2-chloro phenol derivatives 
with suitable acids and chlorine-containing oxidants.19 After many attempts, they found under 
room temperature Pd(OAc)2 catalyst with a small amount of TfOH phenol carbamates substrate 
transformed into the corresponding 2-chloro phenol derivatives by NCS (Scheme 1.2).   
 
3







  In summary, their mechanism could be i) chelate-directed C-H activation of the substrate 
afforded a five-membered cyclopalladium ring ii) TfOH involved in the generation of Pd(OTf)2 
complex iii) Pd(II) was oxidized into a Pd(IV) intermediate iv) reductive elimination to afford 
C-Cl bond products and Pd(IV) will be back to Pd(II) (Scheme 1.2). 
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Biosynthesis of chlorophenol 
  Natural chlorophenols were also found in some species. The blue-green alga Anacystis marina 
contains 4-benzyl-2-chlorophenol. The acorn worm Ptychodera bahamensis produces two 
halogenated phenols 3,4- dichloro- and 3,5-dichlorophenol.20 These biosynthesis paths may also 
inspire scientists to improve our green chemistry synthesis method of chlorophenols.  
 
1.1.3 Yin’s Nucleophilic Selective Chlorination of Quinone Monoketals 
Quinols, as partly oxidized derivatives of phenols, exhibit different functional groups, such as 
the hydroxy group, the double bond, and the carbonyl group. They have been widely used in the 
synthesis of structurally complex molecules.21 One of the main reaction sites on quinols is the 
tertiary alcohol moiety.22A well-known reaction involving this site is cyclohexadienone–phenol 
rearrangement,15 which leads to either hydroquinone or resorcinol products24. Sorgi and colleagues 
reported asymmetric desymmetrization of the double bonds in quinol derivatives via quinol and 
diketene in the presence of a catalytic DMAP afforded a Cope [3,3]-sigmatropic rearrangement 
product arylacetone (Scheme 1.3, a).25 In 2014, our group reported that quinone monoketals, 
regiospecifically differentiated quinone equivalents, offered o-chlorophenols via an unexpected 
nucleophilic chlorination mediated by N,N’-dimethylhydrazine dihydrochloride through a 
regioselective 1,4-addition in situ formed more electron-withdrawing oxocarbenium (Scheme 1.3, 
b).26 For a similar structure between quinol and quinone monoketal, we believe quinol could also 
give chlorophenol between the hydroxyl group and electrophilic chlorination reagent by 
intramolecular rearrangement or intermolecular addition. In order to develop a new protocol for 
halogenation of aromatic compounds and extend the scope of reactivity of quinols in organic 
synthesis, we have investigated thionyl chloride and sulfuryl chloride, two electrophilic 
chlorination reagents, to prepare our reaction with 4-methyl quinol. We have observed that thionyl 
5
sulfuryl chloride offers a new product, while sulfuryl chloride does not offer any new product. This 
product was proved to be 2-chloro-4-methylphenol by compared with the authentic compounds 
2-chloro-4-methylphenol and 3-chloro-4-methylphenol (Fig. 1.1).   
 
Scheme 1.3 Selective addition of quinol and quinone monoketal 
a. Sorgi et al 
 
b. 2014 our work 









Fig. 1.1 1HNMR and 13CNMR for 2-chloro-4-methylphenol and 3-chloro-4-methylphenol. 
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1.2 Selective Chlorination of Quinol to Form o-Chlorophenol with Thionyl Chloride in the 
Presence of Base 
1.2.1 Chlorination of Quinol by Thionyl Chloride 
Scheme 1.4 Chlorination of quinol by thionyl chloride 
 
 
Based on our findings, we initiated our investigation on 4-methyl quinol mixed with thionyl 
chloride (Scheme 1.4). Using Et3N as base and dichloromethane as the solvent, at room 
temperature, the reaction afforded the desired product 1.5a in just 22% yield (Table 1.1, entry 1). 
The hydroxyl group on quinol performs as nucleophilic reagent approaching thionyl chloride, and 
triethylamine accelerates this process by generating hydrogen chloride salt. This low yield is not 
surprising since the chlorination process is an exothermic reaction, and parts of the reagents could 
decompose. However, we optimized the temperature from room temperature (25 °C) to –46 °C. 
The addition of thionyl chloride under ice bath (0 °C, followed by transferring the reaction to room 
temperature (25 °C), was superior to the other conditions, which offered the highest yield, 64%, 
and shortest reaction time, in one hour (entries 2 and 3). When performing the reaction under 0 °C, 
we observed a lower yield (entry 4).  
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Table 1.1 Temperature inferences to chlorination of 4-methyl quinol a 
Entry Reaction Condition Time (h) Yield (%) b 
1 Room Temperature (25 °C) 1 22 
2 Ice bath (0 °C) 4 64 
3 Ice bath (0 °C) then room 
temperature (25 °C) c 
1 62 
4 Acetonitrile Dry ice bath (-46 °C) 4 56 
 a. Reactions was carried out in dichloromethane solution. b. Yield referring to isolated amount of product after 
column chromatography. c. Reaction performed in ice bath (0 °C) for 20 mins. 
 
With exception to dichloromethane, we also set up in other solvents to optimize solvent (Table 
1.2). Both dichloromethane and 1,2-dichloroethane generate desired compound in the same yield 
(entries 1 and 2). When dissolved in THF or dioxane, two ether aprotic solvents, the reaction gave 
white precipitate instead of the chlorination product (entries 3 and 4). The addition of THF leads to 
ClSO-THF complex and thus the coordination ability of THF to the reaction intermediates, which 
could alter the reaction pathways, types, and population of the end products.19 We predicted both 
ethers would perform as nucleophilic reagent formed a precipitate with thionyl chloride. The use 
of acetonitrile as a solvent resulted in no reaction, which thionyl chloride and acetonitrile may 
generate complex (entry 5). Interestingly, the toluene mixture even provided the ortho-addition 
product of about 30% yield (entry 6).  
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Table 1.2 Optimization of reaction solvents a 
Entry Solution Yield (%) b 
1 Dichloromethane 62 
2 1,2-Dichloroethane 61 
3 THF 0      White precipitate in solution 
4 1,4 dioxane 0      White precipitate in solution 
5 Acetonitrile 0       No change in solution 
6 Toluene 30     Solution turns to dark 
a. Reactions were carried out in ice bath (0 °C) for the first 20 mins. b. Yield referring to isolated amount of 
product after column chromatography. 
 
In the absence of base, chlorination can still occur, but the yield lowers to 11% (Table 1.3, entry 
1). Variations of bases were investigated, and results indicated triethylamine, DBU and pyridine 
were found to be equally efficient (Table 1.3, entries 2, 3, and 4). In fact, the addition of any base 
showed an increase in reactivity towards chlorination.  
 
Table 1.3 Optimization of bases 
Entry Base and chloride source Yield (%) a 
1 No base used 11 
2 Et3N 62 
3 DBU 62 
4 Pyridine 61 
a. Yield referring to isolated amount of product after column chromatography. 
 
In Table 1.4, TsCl, sulfuryl chloride, and acyl chloride were examined as chloride sources. All 
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three showed no signs of chlorination (Table 1.4, entries 2, 3, and 4). We proposed that hydroxyl 
quinols are weak nucleophiles that can only be activated with strong electrophiles such as thionyl 
chloride. By introducing additional chloride sources of pyridine hydrochloride or 
tetrabutylammonium chloride, we observed a decrease in the overall yield of desired product 
ortho-chlorophenol to 40%~50% (Table 1.4, entries 5 and 6). These results support our theory that 
selective chlorination happens through an intramolecular rearrangement path. 
 
Table 1.4 Optimization of chlorination reagents a 
Entry Chlorination agent  Yield (%) b 
1 Thionyl chloride 62 
2 TsCl 0 
3 Sulfuryl chloride 0 
4 Acyl chloride 0 
5 Pyridine hydrochloride c 47 
6 TBACl d 43 
a. Reactions was carried out in dichloromethane solution. b. Yield referring to isolated amount of product after 
column chromatography. c. Ratio of extra chloride source pyridine hydrochloride or TBACl to thionyl chloride 
was 1:1. d. Tetrabutylammonium chloride. 
 
With optimized conditions identified, we then explored the scope of quinol structures. All 
quinols are prepared in one step from commercial phenols by PIDA oxidation according to 
Tamura-Kita-Pelter protocol.28 The most promising results obtained from a screen of 18 quinols 
are shown in Table 1.5. As for quinol thionyl chloride chlorination to afford the desired 
o-chlorophenol products 1.5a-1.20a in high yields with moderate to high regioselectivities, 
tolerating substituents such as cyclic, halogen, nitrile, carbonyl, and ester groups. Dimethyl and 
12
trimethyl substitutes quinols such as 2,4-dimethyl 1.6, 3,4-dimethyl 1.7, 3,4,5-trimethyl 1.8 
quinols could offer good yield in 60% (Table 1.5, entries 2, 3, and 4). Notably, when 3,4-diemethyl 
quinol 1.7 was employed as starting material, the desired products were obtained in two isomers 
1.7a and 1.7b, in which the ratio between 1.7a and 1.7b is 22% to 44%, nearly 1 to 2 (entry 3). In 
our opinion, steric effect of meta-methyl could block chloride to attack 2- position leads to 2- 
addition chlorophenol was in lower yield, which was a good proof for quinol-thionyl chloride 
complex should be through an intramolecular path to give chlorophenol; also, 6- position is more 
electrophilic than 2- position that could increase difference in the ratio. Furthermore, ethyl, propyl, 
isopropyl to cyclohexyl quinols 1.9-1.12 could offer particularly well chlorination products in 
good yield around 60% (entries 5 to 8). Although the yield of chloro-cyclohexyl phenol is between 
5% and 6% lower than others, it has been demonstrated that alkyl substitutes on 4- position could 
not have the steric hindrance influence on the hydroxyl group which attackes the electrophilic 
thionyl chloride and produces activated alcohol (entry 8).  
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Table 1.5 Substrate scope of the selective chlorination of quinols 
 
 
Entry Quinol Products Yield (%) a 
1 1.5 

























































































No product   
18 1.22 
R1=Me, R3=COMe, R2, 
R4=H 
 
No product  
a.  Yield referring to isolated amount of product after column chromatography. 
  Since cyclopentyl quinol 1.14a contains 2- and 6- two available positions, the reaction provided 
two isomers 1.14a and 1.14b at 60% yield (entry 10). As can be seen from these two isomers, 
unsurprisingly, the less steric hindrance chlorophenol 1.14b in higher yield 42% compared with 
1.14a at 22% - a ratio of nearly 2 to 1. This regioselectivity of 1.14 agrees with the result of 1.7 and 
can be attributed to intramolecular rearrangement. Cyclic 1.13 gave a 66% yield (entry 9). 
  In the case of electron-rich aromatic phenyl quinol and derivatives, using phenyl quinol 1.15 can 
offer a 68% yield product 1.15a (entry 11). However, bromophenol 1.16 and benzonitrile 1.17, 
17
two quinols with electron-withdrawing substitutes, generated much lower yields than 1.15 (entries 
12 and 13). In fact, the reason could be the electron-withdrawing group as cyano group would not 
stabilize the intermediate structure. However, with both carbonyl structures 1.18 and 1.19, yields 
do not dramatically decrease, which still have the desired product 1.18a, 1.19a at around 60%, 
since these two electron-withdrawing groups not directly attach to aromatic ring (entries 14 and 
15). Then the applicability of two strong electron-withdrawing groups with quinol 1.21, 1.22 were 
also examined, but they could not offer any chlorinated product (entries 17 and 18). We proposed 
that the intermediate resonance structure of ortho-carbonyl may transfer positive charge and block 
further chlorination. Furthermore, 2-bromo quinol 1.20, the yield can still stable at 60% (entry 16). 
 
1.2.2 Mechanism of Regioselective Chlorination 
Table 1.6 Introducing extra or another halogen source 
Entry Halogen Yield (%) a 
1 Pyridine hydrochloride 47 
2 TBACl  43 
3 TBABr  
 
No ortho-bromophenol 
a.Yield referring to isolated amount of product after column chromatography.  
 
  We proposed the selective chlorination of quinol starts from base-catalyzed condition 
nucleophilic hydroxy group approaching thionyl chloride. Initially, we presented an 
intramolecular path to form the o-chloride phenol by rearrangement. Otherwise, we could not deny 
the possibility of an intermolecular path by anion chloride in solution (Scheme 1.3). Depending on 
Sorgi condition, intramolecular rearrangement should be preferred. In the case of intramolecular 
18
rearrangement, if it is possible to have two desired products, the high-yield product will be one 
with less steric hindrance. Otherwise, the intermolecular reaction will generate two isomers in the 
same yield. As previously mentioned, 3,4-dimethyl quinol 1.7 offered two products 1.7a and 1.7b, 
yield ratio was 1 to 2 (Table 1.5, entry 3); quinol 1.14 also generates two products 1.14a and 1.14b, 
which 1.14b is twice as high as 1.14b (Table 1.5, entry 10). Notably, both 1.7b and 1.14b are less 
steric hindrance products following intramolecular rearrangement. Moreover, in Table 1.6. after 
we introduced pyridine hydrochloride and TBACl as extra chloride source, the yield decreased 
(entries 1 and 2). With a new halogen source, TBABr, the new bromine anion should promote 
ortho- bromide phenol in the intermolecular process (entry 3). However, we did not isolate the new 
halogenation product. The regioselectivity of 1.7 and 1.14 agrees with the results obtained for the 
reaction of extra chloride and bromide introduction and can be attributed to intramolecular 
rearrangement in the transition state.    
  
19







In conclusion, we have demonstrated a new selective nucleophilic chlorination of quinol to 
afford ortho- chloride phenol. This one-step selective chlorination can easily be performed using 
readily available quinols and thionyl chloride. This conversion benefits from a simple procedure, 
gentle conditions, and low-cost reagents without any expensive catalyst. At present, the reaction 
has an acceptable yield of around 60%, however, the possible side products HCl and SO2 are 
disadvantages to green chemistry principles. For our next step, we will try to improve the reaction 
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General Information  
Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were 
purchased from commercial sources or synthesized using methods from the literature. 1H and 13C 
NMR spectra were recorded on BRUKE 500 MHz spectrometers; 1H and 13C NMR chemical 
shifts (δ values) were reported in ppm from downfield using internal standard TMS (1H NMR) or 
CDCl3(13C NMR), respectively. All mass spectra were run by the Hunter College Mass 
Spectrometry Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All 
infrared spectra were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography 
was performed over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling 
constant (J) are reported in units of hertz (Hz). The following abbreviations are used to describe 
multiplets: s (singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), sept (septet), m 
(multiplet), br (broad).   
 
Preparation of Quinol 
Quinol are made from oxidation of phenols by phenyl iodo diacetate (PIDA) following general 
procedures of and verified by 1H and 13C NMR. 
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Chlorination of quinol with thionyl chloride 
 
  1.5                           1.5a 
1.5a: 2-chloro-4-methylphenol 
Quinol 1.5 (1 mmol, 124 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
Product is yellow oil. Yield: 79 mg, 64%.  
62% yield; 1H NMR (500 MHz, CDCl3) δ 7.12 (s, 1 H); 6.97 (d, J=2 Hz, 1 H); 6.88 (d, J=8 Hz, 1 
H); 5.35, 13C NMR (500 MHz, CDCl3) δ 149.01, 130.98, 129.14, 128.97, 119.37, 115.77, 20.21. 
MS m/z calculated for C7H7ClO [M+H+] 143.0, found 143.1. 
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1.6a: 2-chloro-4,6-dimethylphenol 
Quinol 1.6 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 oC. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 87 mg, 63%. 
64% yield; 1H NMR (500 MHz, CDCl3) δ 7.07 (s, 1 H); 6.95 (s, 1 H); 2.39 (s, 3 H); 2.28 (s, 3 H); 
13C NMR (500 MHz, CDCl3) δ 141.86; 137.29; 134.68; 130.63; 128.26; 126.38; 20.72; 17.58. MS 
m/z calculated for C8H9ClO [M+H+] 157.0, found 157.0. 
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 1.7a               1.7b 
1.7a: 2-chloro-3,4-dimethylphenol; 1.7b: 2-chloro-4,5-dimethylphenol 
Quinol 9 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) to room temperature and stirred for 2 hours. The reaction was then quenched 
with sodium bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 
ml). Then the organic layer was washed with brine water (1 ml) and dried over Na2SO4. After 
filtration, then extract was concentrated, and the residue was purified by chromatography 
(EtOAc/Hexane 1/10). The product is yellow oil. Yield: 1.7a, 30 mg, 22%; 1.7b, 60 mg, 44%. MS 
m/z calculated for C8H9ClO [M+H+] 157.0, found 157.1. 
1.7a: 22% yield; 1H NMR (500 MHz, CDCl3) δ 6.96 (d, J=10 Hz, 1 H); 6.79 (d, J=10 Hz, 1 H); 
2.30 (s, 3 H); 2.29 (s, 3 H); 13C NMR (500 MHz, CDCl3) δ 148.95, 149.33, 134.66, 129.40, 128.63, 
120.65, 116.29. 
1.7b: 44% yield; 1H NMR (500 MHz, CDCl3) δ 7.05(s, 1 H); 6.80 (s, 1 H); 2.18 (s, 3 H); 2.15 (s, 3 






Quinol 1.8 (1 mmol, 152 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 85 mg, 56%. 
1.8a: 56% yield; 1H NMR (500 MHz, CDCl3) δ 6.72 (s, 1 H); 5.39 (s, 1 H); 2.33 (s, 3 H); 2.23 (s, 
3 H); 2.14 (s, 3 H); 13C NMR (500 MHz, CDCl3) δ 148.56; 135.96; 134.18; 128.01; 123.05; 118.01; 





Quinol 1.9 (1 mmol, 138 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 85 mg, 62%. 
1.9a: 62% yield; 1H NMR (500 MHz, CDCl3) δ 7.14 (s, 1 H); 6.99 (d, J=5 Hz, 1 H); 6.91 (d, J=10 
Hz, 1 H); 2.53 (q, J=5 Hz, 2 H); 1.18 (t, J=5 Hz, 2 H); 13C NMR (500 MHz, CDCl3) 149.14, 137.52, 





Quinol 1.10 (1 mmol, 153 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 98 mg, 64%. 
1.10a: 64% yield; 1H NMR (500 MHz, CDCl3) δ 7.12 (d, J=2 Hz, 1 H), 6.96 (dd, J=1.5 Hz, J=8 Hz, 
1 H), 6.91 (d, J=8 Hz, 1 H), 2.47 (t, J=8 Hz, 2 H), 1.55 (m, J=7.5 Hz, 2 H), 0.90 (t, J=7.5 Hz, 3 H); 
13C NMR (500 MHz, CDCl3) δ 149.17, 135.96, 128.59, 128.40, 119.38, 115.85, 36.88, 24.57, 






Quinol 1.11 (1 mmol, 153 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 100 mg, 65%. 
1.11a: 65% yield; 1H NMR (500 MHz, CDCl3) δ 6.69 (d, J=3.5 Hz, 1 H), 6.63 (d, J=10 Hz, 1 H), 
6.54(dd, J=3.5 Hz, J=10 Hz, 1 H), 3.19 (m, J=9 Hz, 1 H), 1.23 (d, J=8.5 Hz, 6 H); 13C NMR(500 
MHz, CDCl3) δ 149.59, 146.63, 135.92, 116.06, 113.39, 112.89, 29.70, 27.11, 22.50. MS m/z 






Quinol 1.12 (1 mmol, 192 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 106 mg, 55%. 
55% yield; 1H NMR (500 MHz, CDCl3) δ 7.14 (d, J=2 Hz, 1 H), 6.99 (dd, J=2 Hz, J=8 Hz, 1 H), 
6.91 (d, J=8.5 Hz, 1 H), 5.44 (s, 1 H), 2.38 (m, J=3 Hz, J=8 Hz, 1 H), 1.81 (t, J=9 Hz, 4 H), 1.71 (d, 
J=15 Hz, 1 H), 1.33 (m, J=6 Hz, 4 H), 1.28 (m, J=3.5 Hz, 1 H); 13C NMR (500 MHz, CDCl3) δ 
149.18, 141.54, 127.02, 126.79, 43.52, 34.54, 26.78, 26.02. MS m/z calculated for C12H15ClO 






Quinol 1.13 (1 mmol, 164 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 108 mg, 66%. 
1.13a: 66% yield; 1H NMR (500 MHz, CDCl3) δ 6.91 (s, 1 H), 5.33 (s, 1 H), 2.91 (t, J=7.5 Hz, 2 H), 
2.78 (t, J=7.5 Hz, 2 H), 2.22 (s, 3 H), 2.12 (m, J=1.0 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 
145.38, 144.12, 130.43, 126.38, 116.69, 31.67, 30.96, 29.84, 18.30. MS m/z calculated for 




         
1.14a            1.14b 
1.14a: 4-chloro-2,3-dihydro-1H-inden-5-ol; 
1.14b: 6-chloro-2,3-dihydro-1H-inden-5-ol.  
Quinol 1.14 (1 mmol, 150 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0oC. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield:  1.14a, 33 mg, 22%; 1.14b, 63 mg, 42%. 
1.14a: 22% yield; 1H NMR (500 MHz, CDCl3) δ 6.92 (d, J=10 Hz, 1 H), 6.73 (d, J=8 Hz, 1 H), 
5.32 (s, 1 H), 2.86 (m, J=8 Hz, 4 H), 2.05(m, J=7.5 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 
149.68, 141.52, 137.29, 123.21, 111.94, 33.09, 32.59, 25.90.  
1.14b: 42% yield; 1H NMR (500 MHz, CDCl3) δ 7.05 (s, 1 H), 6.79 (s, 1 H), 5.34 (s, 1 H), 2.76 (m, 
J=7.5 Hz, 4 H), 1.97 (m, J=7.5 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 149.54, 144.92, 137.14, 






Quinol 1.15 (1 mmol, 186 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 126 mg, 68%. 
1.15a: 68% yield; 1H NMR (500 MHz, CDCl3) δ 7.55 (d, J=2 Hz, 1 H), 7.52 (d, J=1 Hz, J=2 H), 
7.41 (t, J=7.5 Hz, 3 H), 7.31 (t, J=7.5 Hz, 1 H), 5.55 (s, 1 H); 13C NMR (500 MHz, CDCl3) δ 
150.73, 139.56, 134.98, 128.85, 128.72, 127.48, 127.14,126.71, 120.24, 116.48, 115.63. MS m/z 






   
1.16a: 4'-bromo-3-chlorobiphenyl-4-ol 
Quinol 1.16 (1 mmol, 264 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 106 mg, 40%. 
1.16a: 40% yield; 1H NMR (500 MHz, CDCl3) δ 7.55 (m, J=7 Hz, 3 H), 7.38 (d, J=8.5 Hz, 3 H), 
7.09 (d, J=8.5 Hz, 1 H); 13C NMR (500 MHz, CDCl3) δ 151.03, 138.46, 133.62, 131.97, 128.30, 






Quinol 1.17 (1 mmol, 211 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 65 mg, 31%. 
1.17a: 31% yield; 1H NMR (500 MHz, CDCl3) δ 7.65 (d, J=8.5 Hz, 2 H), 7.55(d, J=8 Hz, 2 H), 
7.51(d, J=1.5 Hz, 1 H), 7.37(dd, J=1.5 Hz, J=8.5 Hz, 1 H), 7.07(d, J=8.5 Hz, 1 H); 13C NMR (500 
MHz, CDCl3) δ 151.88, 143.92, 132.73, 127.73, 127.34, 127.23, 118.87, 116.91, 115.30, 110.84. 




1.18a: 1-(3-chloro-4-hydroxyphenyl) propan-2-one 
Quinol 1.18 (1 mmol, 166 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 96 mg, 58%. 
58% yield; 1H NMR (500 MHz, CDCl3) δ 7.26 (s, 1 H); 6.99 (d, J=8.5 Hz, 1 H); 6.96 (d, J=8.5 Hz, 
1 H); 5.67 (s, 1 H); 3.62 (s, 1 H); 2.17(s, 3 H); 13C NMR (500 MHz, CDCl3) δ 206.25; 150.49; 
129.79; 129.45; 127.20; 120.00; 116.44; 49.54; 29.36. MS m/z calculated for C9H9ClO2 [M+H+] 




1.19a: ethyl 2-(3-chloro-4-hydroxyphenyl) acetate 
Quinol 1.19 (1 mmol, 182 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, then 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield: 109 mg, 60%. 
60% yield; 1H NMR (500 MHz, CDCl3) δ 7.24 (d, J=1.5 Hz, 1 H), 7.05 (dd, J=8.5 Hz, J=2 Hz，1 
H), 6.92 (d, J=8 Hz, 1 H), 5.80 (s, 1 H), 3.70 (s, 3 H), 3.53 (s, 2 H); 13C NMR (500 MHz, CDCl3) 
δ 172.09, 150.59, 129.77, 129.30, 126.91, 119.89, 116.33, 52.26, 39.93. MS m/z calculated for 





Quinol 1.20 (1 mmol, 203 mg) was dissolved in DCM (3 ml) with triethylamine (1 mmol, 101 mg, 
0.14 ml) at 0 °C. Thionyl chloride (1.2 mmol, 143 mg, 0.09 ml) was injected slowly. After 10 
minutes of the addition of thionyl chloride, the reaction mixture was transferred under room 
temperature (25 °C) and stirred for 2 hours. The reaction was then quenched with sodium 
bicarbonate saturated solution (2 ml) and the solvent was extracted with DCM (3*2 ml). Then the 
organic layer was washed with brine water (1 ml) and dried over Na2SO4. After filtration, the 
extract was concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
The product is yellow oil. Yield:148 mg, 73%. 
1H NMR (500 MHz, CDCl3) δ 7.12 (s, 1 H), 7.00 (s, 1 H), 5.55 (s, 1 H), 3.31 (s, 3 H); 13C NMR 
(500 MHz, CDCl3) δ 145.22, 134.56, 132. 18, 129.21, 126.35, 21.11. MS m/z calculated for 































Chapter 2 Deoxofluorination between Diethylaminousulfur 
Trifluoride (DAST) and Quinol 
2.1 Fluorine Chemistry from Past to Now on  
2.1.1 Fluorine Chemistry from 19th Century to Modern Time 1, 2  
Fluorine, its element name came from ‘fluor’ in mineral fluorspar which today called calcium 
fluoride. The ‘fluor’ in the Latin word ‘fluere’ means ‘to flow’ since it was added to metal ores to 
lower their melting points for smelting. However, many talented chemists were killed by this fatal 
element on the isolating process, even those injured, and death called ‘fluorine martyrs.’ Those 
early pioneers such as Davy, Gay-Lussac, and Thenard all suffered intensely from the effects of 
inhaling small quantities of hydrogen fluoride vapor; Davy’s eyes also were damaged by the gas.1 
Two members of the Royal Irish Academy, George Knox and his brother, the Reverend Thomas 
Knox, were unable to liberate the halogen from fluorspar, and both suffered the frightful torture of 
hydrofluoric acid poisoning.3 The Reverend Thomas Knox nearly lost his life, and George Knox 
had to rest in Naples for three years to regain his health. P. Louyet of Brussels, under full 
knowledge of the Knox brothers’ misfortune, continued his dangerous researches and devoted his 
life to science4-6. Professor Jerome Nickles of Nancy met a similar fate.7-9 French chemist Henri 
Moissan, continued the search of isolating fluorine after his mentor Edmond Frémy. After many 
unsuccessful attempts to electrolyze fluoride and poisoned by side products, Moissan finally used 
electrolyte, which was a solution of dry potassium acid fluoride in anhydrous hydrofluoric acid. 
On June 26, 1886, a gas appeared at the anode, and when he tested it with silicon, it immediately 
burst into flame. The burning product was proved as silicon fluoride and the small gas bubble was 
pure fluorine. This is the first-time chemist isolated fluorine element and Henri Moissan received 
the 1906 Nobel Prize in Chemistry for his achievement. 
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  Belgian chemist, Frédéric Swarts, a professor in the civil engineer at the University of Ghent, 
started his studies on the preparation of fluorocarbon compounds around 1890. From 1900 he was 
virtually the only worker publishing in the field.11 During his work until to 1938, he contributed a 
great deal in outlining methods of preparation for many partly fluorinated compounds. Swarts 
made trifluoroacetic acid as early as 1922 and in 1931 reported synthesis of pure perfluoroethane 
by electrolysis of an aqueous solution.12-13 Midgley and Henne were able to apply fluoromethanes 
and ethanes as refrigerants by basing on Swarts’ work in 1930.14 Lebeau and Damiens reported 
tetrafluoromethane in 1926 which was the first pure isolated perfluorocarbon.15 The first liquid 
perfluorocarbon was introduced in 1937 when Simons and Block found that mercury promotes 
reaction between carbon and fluorine which were able to isolate CF4, C2F6, C3F8, C4F10 (two 
isomers), cyclo-C6F12 and C6F14.
16 Tetrafluoroethene was obtained by Ruff and Bretschneider in 
1933, who decomposed tetrafluoromethane in an electric arc while Locke developed a synthesis 
in 1934, which involved zinc dehalogenation of CF2Cl2CF2Cl.
17-18 Early fluoropolymer, 
polytetrafluoroethylene was discovered in 1938 and then polymerized chlorotrifluoroethylene 
which was proved as a very stable inert transparent polymer.19 In the Second World War period, 
the war involved the development of fluoropolymer and other new materials, and the potential of 
fluorinated compounds was recognized by chemists. So, after the war, organofluorine progress has 
been extremely rapid. In the 1950s, many fluoride functional derivatives were synthesized, and a 
new area fluorocarbon organometallic chemistry was in chemists’ eyes. Non-flammable fluorine-
containing inhalation anesthetics was introduced as the synthesis of the earliest fluorinated drugs. 
Fluorinated elastomers are critical materials in the development of supersonic and space light. 
Then from the 1960s to now on, perfluoro aromatic chemistry was rapidly developed, selective 
methods for fluorination were introduced, and more and more fluorinated compounds play an 
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increasingly important role in the pharmaceutical and plant-protection.20 In the early 1990s, 6.2% 
compounds registered in Chemical Abstracts (CA) own C-F bound. Industry sources estimate that 
as many as 30-40% of agrochemicals and 20% of pharmaceuticals on the market contain fluorine.21 
Also fluorine is used to tag biochemical probes for the study of various biological processes, as 
the NMR activity of the 19F nuclei enables in vivo magnetic resonance imaging.21 In addition, 18F-
positron-emitting tomography is used daily for diagnosing, staging, and detecting the recurrence 
or progression of various diseases including cancer.22 Organofluorine chemistry is an outstanding 
output for the relatively limited number of workers in the field worldwide and is a tribute to their 
dedication.23 
 
2.1.2 Typical Organofluorine Compounds 
Natural Organofluorine Product 
Even the fluorine is the 13th richest element on Earth’s crust (Chlorine ranks 20th) and the most 
common halogen, natural products with fluorine are still the rarest and only about a dozen 
fluorinated natural products have been isolated.24 This confusing puzzle can be explained as 1) 
fluorspar (CaF2) and cryolite (Na3AlF6) contain most fluorine as minerals, which hardly delivery 
to aqueous biological systems; 2) the highest oxidation potential of fluorine obstructs through 
enzymatic halogenation pathway to form intermediate hypohalous species by vanadium dependent 
halogenases and H2O2; 3) fluorine is a poor nucleophile under aqueous biological conditions by 
its extraordinary high hydration energy which the general nucleophilic opening of epoxide 
intermediates with halide anions by enzymatic incorporation is blocked; 4) the last pathway for 
biological halogenation involves a radical mechanism, however fluorine’s radical is difficult to 
generate and its violent reactivity would prevent any regio/chemoselectivity.25 The first fluorinase 
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enzyme has been discovered that catalyzes carbon-fluorine bond formation in 200226 from 
bacterium Streptomyces cattleya and until 2007 other 9 structures of this class of enzyme were 




Fig 2.1 The fluorinase enzyme from Streptomyces cattleya mediates the conversion of S-adenosyl-
L-methionine (SAM) to 5’-fluoro-5’-deoxyadenosine (5’-FDA)  
 
The first natural fluorine product was found in 1943, fluoroacetate, which is a metabolite of the 
Southern African plant Dichapetalum cymosum.27 Monofluoroacetate also can produce by tropical 
and subtropical plants Palicourea marcgravii, Acacia georginae, Gastrolobium grandiflorum, and 
Oxylobium species.28 Plants with monofluoroacetate are toxic and have negatively affected 
livestock production in the worldwide area throughout recorded history. They caused livestock 
sudden death and heavy losses in South Africa, Australia and other areas in the world. 
Nevertheless, people also employed sodium monofluoroacetate as a pesticide on the control of 
mammalian pests such as rodents, introduced foxes, feral dogs and cats, introduced possums, and 
native predators such as coyotes.29 Other natural organofluorine compounds, 4-fluorothreonine is 
fluorine contained amino acids as a co-product of monofluoroacetate in bio-synthesis.30 
Fluorocitrate is also found in some of the toxic plants but in low concentration. ω-Fluorooleic acid 
was isolated from Datura toxicarium also as a toxin. Nucleocidin has been considered as an 
antibiotic, but it has proven difficult to explore the biosynthesis of this metabolite as the strains 
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deposited in public collections do not have the capacity to biosynthesize the antibiotic, so the 
nature of fluorine incorporation into nucleocidin is unresolved.31 
 
 
Fig 2.2 Natural fluorine products 
 
Organofluorine Pharmaceuticals 
Organofluorine compounds attract more and more attention from global scientists for their 
important pharmaceutical performing. By estimating nearly 20% of pharmaceuticals prescribed or 
administered in the clinic contain a fluorine atom and 30% of leading 30 blockbuster drugs by 
sales contain a fluorine.32 Effect of fluorine can strongly modify physicochemical properties in 
lipophilicity, conformation, hydrogen bonding, electrostatic interactions and pharmacokinetic 




Fig 2.3 Fluoxetine, commercial brand name Prozac 
Fluoxetine, the commercial brand name Prozac, is a well-known antidepressant drug, featuring 
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a trifluoromethyl group on one of its aryl rings. It was synthesized by Eli Lilly in 1974 and 
approved by the Food and Drug Administration (FDA) in 1987. The annual sales in the U.S. 
reached $350 million within a year and world worldwide sales reached $2.6 billion a year at a 
peak. Fluoxetine acts by selectively inhibiting the reuptake of serotonin of which low level can 
lead depressants. It is believed that the steric bulk of the trifluoromethyl group at this position 
allows the phenoxy ring to adopt a conformation which favors binding to the serotonin transporter, 
especially the potency for inhibiting of trifluoromethyl group in the para- position is much higher 




Fig 2.4 5-Fluorouracil and Capecitabine 
 
5-fluorouracil is one of those earliest synthetic fluorinated drugs which was finished in 1957 as 
antimetabolite used in chemotherapy for cancer.35 This drug has two primary mechanisms of action 
capable of inducing cytotoxicity. First, 5-fluorouracil is phosphorylated to fluorouridine 
triphosphate, a fraudulent nucleotide, which is incorporated into RNA by RNA polymerase, 
inhibiting RNA synthesis and function. Second, it inhibits thymidylate synthetase, depleting 
intracellular levels of thymidine monophosphate and thymidine triphosphate which are essential 
for DNA synthesis.36 However. The 5-fluorouracil has strong toxicity to lead side effects, diarrhea, 
nausea, sores, poor appetite, and other uncomfortable conditions to more than 30% of patients. 
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Therefore, using strategies to reduce such side effects has been highly pursued. In this case, a new 
medicine Capecitabine was synthesized and launched by Roche. In 2011, Capecitabine was 
reported producing a $1.532 billion sales amount.37 
 
 
Fig 2.5 Atorvastatin (Lipitor) 
 
 
  Lipitor (atorvastatin calcium) was the first drug to reach the annual sales of 10 billion dollars and 
currently is one of the top-selling pharmaceutical products in the world.38 It belongs to the statin 
medication family, which is HMG-CoA reductase inhibitor. Atorvastatin, was proved to lower the 
risk for heart attack, stroke, certain types of heart surgery since it can reduce LDL-C level and 
increase HDL-C level.39 According to reports, Lipitor in moderate- to high-risk patients were 
achieved at a relatively low incremental cost and, across the economic analyses, a substantial 
proportion of atorvastatin acquisition costs was offset by reductions in healthcare resource use 
associated with cardiovascular events.40 
 
2.1.3 Interaction of C-F Bonds41 
Since fluorine is highly electronegative and fluoronium species F+ has never been observed, the 
C-F bond is highly polarized, less covalent and more electrostatic. The C-H bond and C-F bond 
will be different in (a) electronegativity differences, (b) the existence of unshared electron pairs 
associated with fluorine, (c) the tendency for displacement of fluorine as F from unsaturated 
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fluorocarbons, (d) the higher bond strength of C-F than C-H and, to a lesser extent, (e) the larger 
size of fluorine than hydrogen.42 Then we also can expect the C-F bond to other halogen carbon 
bond especially the C-Cl bond have difference in (a) the larger steric requirements, (b) the lower 
bond strength of C-Cl than C-F, and (c) the greater availability of 3d orbitals of chlorine.43 
 
C-F bond is the strongest bond in organic chemistry since bond dissociation energy is much 
higher than C-H, C-O, and C-Cl. Fluorine has the greatest propensity to attract electron density 
and electron density particular on fluorine, so the electrostatic attraction between Cδ+ and Fδ- 
contributes more bond strength than classical electron sharing of a covalent bond in C-F bond. 
This polarization of the C-F bond leads to geometric changes in hydrocarbons.44 The fluorine pulls 
valence electron density towards it and this relaxes the electron repulsion between the electron-
rich C-H bonds, so they spread out a little. In CH3F, the H-C-H angle widens but the H-C-F angle 
shrinks, comparing with CH4.
45 On the opposite, the strongest polarity of the C-F bond does not 
make fluorine become the best leaving group. Fluorine ion is the poorest leaving group even carbon 
with a strong positive charge on itself should attract nucleophiles very well. Electrostatic stabilizes 
the C-F bond and resists polarization toward free fluoride ions. Then the electrostatic also gives a 
large dipole moment in the C-F bond, if when compounds with other substitutes offering dipole 
moment, the molecular conformations are rearranged by dipole-dipole interactions, which some 
steric structures will be favored.  
 
Considering the polarity of the C-F bond and three lone pairs on fluorine, fluorine should act as 
a good hydrogen bond acceptor. However, organic fluorine compounds only form weak hydrogen 
bonds. First, because great electronegativity and low polarizability of fluorine which holds its lone 
pairs, suppresses its electrostatic influence and renders it a poor hydrogen bond acceptor.46 Second, 
the C-H bond is also a weak hydrogen bond donor. Thus, fluorine also cannot act as π-donor, or 
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Fig.2.6 The fluorine long hydrocarbon chain performs a helical arrangement of the C-F bonds but 
not an anti-zigzag structure in all-syn multivicinal fluorinated chain. 
 
The C-F bond’s hyperconjugation effect for a highly polarized aspect of the C-F bond is the 
presence of a low lying σ* C-F antibonding orbital. In 1,2-difluoroethane, two fluorine atoms 
prefer a gauche rather than an anti-conformation which is opposite to other 1.2-dihalogen 
compounds, because the gauche conformer supports hyperconjugation model σC-H…σ*C-F 
interactions. Then in 1,3-fluorine bond, the two fluorine atoms repel each other to form σC-
H…σ*C-F interactions. Combinations of the 1,2-gauche effect and 1,3-dipolar repulsion reveal 
themselves in the lowest energy conformations of all-syn multivicinal fluorinated chains.48 The 
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2.2 Fluorination of Quinol  
2.2.1 Synthesis of Complex Organofluorine Compounds 
  At an early age, the organofluorine compounds based on the synthesis of small molecular 
compounds through gas F2, HF and metal fluorides. However, they are expensive and high toxins. 
The general strategies of synthesis of the C-F bond can be nucleophilic, electrophilic, and radical. 
The nucleophilic fluorination is probably the most important route to fluorinated fine chemicals in 
all three paths. The fluoride ion acts as the nucleophile while in reaction. Traditionally, alkali metal 
fluorides like KF, CsF are used as fluorine sources but their low solubility in organic solvent 
influences the effectiveness of the method. HF-based reagents HF/pyridine, Et3N·3HF are 
employed to introduce fluorine to other substrates. Hypervalent halogen derivatives were 
developed in the 1980s, by Tsushima and co-workers with para-iodotoluene difluoride for a 
fluorination reaction.1 The tetraalkylammonium fluorides are widely used fluorine agent, as TBAF 
and sources related to TBAF.2-3 In electrophilic fluorination, the nucleophilic substrates choose 
from carbanion, an electron-rich unsaturated double bond, or a substrate bearing a nucleophilic 
and labile bond. However, the electrophile is a reagent that delivers an equivalent of “F+”, 
traditionally with O-F bond, Xe-F bond or F-F bond. These reagents face problems like high 
reactivity, low selectivity, and absence of commercial sources. In the past years, scientists 
improved the electrophilic strategy with N-F reagent, for example, 1-chloromethyl-4-fluoro-1,4-
diazoniabicyclo [2.2.2] octane bis(tetrafluoroborate), which is one of the best reagents used as an 
electrophilic fluorine donor. Radical fluorination also faces problems which most reagents are 
expensive noble gas reagent or high hazardous reagents, since a carbon-based radical and atomic 
fluorine sources which mostly has been restricted to molecular F2, hypofluorites, and XeF2 
(radical). 
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2.2.2 Fluorination of Quinol. 
  Quinols as an oxidation product of phenol in a water solution containing functional groups 
ketone, hydroxy and diene, perform a very special chemical activity in the synthesis of complex 
compounds. In 2013, we published the synthesis of bicyclic oxazolidinones from quinols and 
isocyanates.4 And we also continue to develop a new one-spot synthesis of acridones from quinols. 
Recently, approaching o-chlorophenol by quinol and thionyl chloride in mild condition with 
activated hydroxyl group performing nucleophile addition was developed by us (Chapter one). The 
findings from these studies suggest that quinol can offer complex building blocks with a 
nucleophilic reagent. Therefore, even if fluoride acting as a weak nucleophile, it also can be 
expected that activated hydroxyl group with fluoride nucleophile reagent can also achieve 
fluorophenol. Karam and co-workers found the ipso-fluorination of para-substituted phenols in 
PIDA or PIFA oxidation process with Olah reagent (pyridinium polyhydrogen fluoride).5 
However, their study did not consider the wide range and complex structures and another weakness 
was that Olah reagent is highly toxic and unstable.   
 
  
Fig 2.7 Karam’s oxidative ipso-fluorination of para-substituted phenols using pyridinium 
polyhydrogen fluoride in combination with hypervalent iodine (III) reagents.  
 
  Various strategies have been considered for the synthesis of new fluorination quinol. As 
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nucleophilic fluorination, the widely choosing reagents concluding metal fluoride, 
trifluormehansulfonic, TBAF (tetra-n-butylammonium fluoride), hydrogen fluoride pyridine and 
DAST has been envisioned. Trifluoromethanesulfonic anhydride, methanesulfonic anhydride, and 
diphenyl phosphoryl chloride all can be reagent to activate hydroxyl group. However, fluoride is 
not as good as chloride in ortho addition since fluoride was a weak nucleophile in the protic 
environment. We failed to obtain the desired product by alkali metal fluoride KF, CsF and 
transition metal fluoride AgF. Considering metal fluoride fluorination mostly focuses on Pd (0) 
cross-coupling, metal fluoride may not be a good fluorine source in deoxofluorination.6 
Trifluoromethanesulfonic anhydride and methanesulfonic anhydride both give ortho- addition new 
products, but these products are trifluoromethanesulfonic and methanesulfonic addition phenol, 
not fluorination phenol. In contrast to other fluoride reagents, however, deoxofluorination reagent 
DAST (Dialkylamionosuflur trifluoride) generated a new fluorinated product which was proved 
as fluorinated quinol not expecting ortho- fluorinated phenol (Scheme 2.1).  
 










2.2.3 Deoxofluorination in Quinols7 
  Dialkylamionosuflur trifluoride (DAST) refers to deoxofluorination reagent, which is an easy to 
handle fluorinating reagent useful for replacing hydroxyl with fluorine under very mild condition. 
Deoxofluorination reagent attracts the hydroxyl group of the substrate on sulfur and the elimination 
of one fluoride generates an alkoxyaminosulfur difluoride intermediate. The eliminated fluoride 
ion will replace alkloxyaminosulfur difluoride to offer products, and this process can be SN1 or 
SN2 nucleophilic pathway.
8 In all those deoxofluorinating agents DAST and Deoxo-Fluor9 are the 
most used.10 
           
Table 2.1 DAST deoxofluorination in different solvent conditions a b 
Entry Solvent Yield (%) c 
1 Dichloromethane 30 
2 1,2-dichloroethane 30 
3 THF Trace 
4 Ethyl ether Trace 
5 1,4-dioxane Trace 
6 Acetonitrile Trace 
7 Toluene No product 
a All reactions 1 mmol 4-methyl quinol and 1.2 mmol Dialkylamionosuflur trifluoride (DAST) were used. b All 
reactions performed in ice bath (0 °C) for 2 hours. c Yield referring to isolated amount of product after column 
chromatography. 
 
To optimize the yield of fluorination quinol, different solvents are screened, such as THF, ethyl 
ether, 1,4-dioxane, toluene, dichloromethane and 1,2-dichloromethane (Table 2.1). The best 
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solvent is dichloromethane in 30% yield and 1,2-dichloromethane can be in the same yield (entries 
1 and 2). THF, ethyl ether, and 1,4-dioxane offer trace or no product, because DAST may activate 
O in ether to reduce reactivity (entries 3, 4 and 5). Acetonitrile in the same situation only can 
provide a trace amount product (entry 6). Two new products are formed in toluene but 19F NMR 
characterized that they are not fluoride compound (entry 7).   
 
Table 2.2 DAST deoxofluorination from low to room temperature a 
Entry Temperature (°C) Yield (%) b 
1 20 (Room Temperature) 28 
2 0 (Ice bath) 30 
3 -46 (Dry Ice-Acetonitrile) 30 
4 -78 (Dry Ice-Acetone) c 30 
a Reagents and conditions: 4-methyl quinol (1 mmol), DAST (1.2 mmol), dichloromethane 2 hours. b Yield referring 
to isolated amount of product after column chromatography. c Reaction finished in 4 hours. 
 
Further temperature screening with DAST revealed that 0 °C showed the best yield (Table 2.2). 
DAST is well stable under room temperature (25 °C) or lower temperature condition, but side 
product of deoxofluorination HF limited reaction in high-temperature condition. We noted that 
room temperature (25 °C), ice bath (0 °C), dry ice-acetonitrile (-46 °C) and dry ice-acetone (-78 
°C), reaction generated same level yield around 30% (entries 1 to 4). However, it was found under 
room temperature (25 °C) reaction offered more side products and dry ice-acetone bath (-78 °C) 
reaction time must extend to 4 hours (entries 3 and 4). 
 
2.2.4 Experimental Scope of Quinols with DAST 
Under the optimized reaction conditions using a wide range of quinols, which are readily 
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prepared in one step from commercially available phenols11, we explored the scope of quinol 
fluorination synthesis with DAST. Representative results are summarized in Table 2.3, 2.4 and 2.5. 
 
Table 2.3 Fluorination of one and multi substitutes quinol 
Entry Quinol Product Yield (%) a  
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a Yield referring to isolated amount of product after column chromatography. 
 
 
We began our investigation by treating one substitute quinol 2.1, 2.2, 2.3, and 2.4 with DAST. 
The desired fluorination quinol product methyl 2.1a, ethyl 2.2a, propyl 2.3a, and isopropyl 2.4a 
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revealed that there had been a slightly yield raised with bigger para-alky groups (entries 1 to 4). 
We suspected the steric effect in deoxofluorination has hyperconjugation effect on the reactivity, 
otherwise, alkyl substituents could increase new product forming by disrupted electrons on quinol. 
Following the same strategy, multi-substitute results the ortho- and meta- dimethyl products 2.5a, 
2.6a, both are in good yield around 50% (entries 5 and 6); 2,3,4 and 3,4,5 trimethyl quinol 2.7a, 
2.8a can provide same yield range (entries 7 and 9). 
 
Table 2.4 Fluorinated product of Cyclo- and Aryl- papa-quinol  


















































a Yield referring to isolated amount of product after column chromatography. 
 
 
Based on the successful synthesis of multi-substituted fluorination quinols, our strategy can be 
extended to more complex quinol structures. All new compounds 2.10a, 2.11a, 2.12a, and 2.13a 
are in a moderate yield of around 50% (entries 10 to 13). However, the main weakness was 
observed that cyclopentane and cyclohexane quinol fluorination products 2.10a, 2.11a, 2.12a were 
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very unstable at room temperature after vacuuming concentration. Although those products 
collected from flash chromatography and vacuum in yellow oil, they turned into solid just in a few 
hours. Fresh 2.10a, 2.11a, and 2.12a were characterized by 1H, 13C, and 19F NMR, otherwise, the 
new solid compounds did not obtain any valuable NMR signal to prove their structure. The absence 
of 19F proved they decomposed in hours after exposure in the air. For example, the original fresh 
2.10a was isolated as clear yellow oil liquid but it quickly turned into blue solid after 6 h. 
Considering 2.13a the cyclohexane derivative is a stable one and in 70% high yield, we proposed 
the cyclo- substitute fluoride structure can cause ring structure extension or C-F bond shrinks bond 
angle to decompose the structure. Unfortunately, aromatic substituted quinols offered fluorinated 
results 2.14a and 2.15a which were facing the same problem, very unstable after concentrated, 
decomposing in 3~4 hours (entries 14 and 15). However, 2.16a as the only solid fluorinate product, 
it was not only the most stable one after isolated but also in the highest yield 96% (entry 16). We 
assumed, there was no simple reason that can explain why these fluorinated quinols were more 
unstable than others. We suspected phenyl- and bromophenyl- as electron-donating groups, which 
can stabilize the cation after fluoride’s leaving, but the cyano group as an electron-withdrawing 
makes it harder to generate the cation. 
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Table 2.5 Fluorination of carbonyl and halide quinol 


























a Yield referring to isolated amount of product after column chromatography. 
 
 
Next, we examined the reactions of carbonyl substituents. As shown in table 2.5, the other 
carbonyl type 2.17a and 2.18a both are in excellent yield 70% to 88%, and excellent stability under 
room temperature (entries 17 and 18). Halogenated substituents 2.19, 2.20 also performed well 
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results, probably meta-bold is less hindered than 2.20 (entries 19 and 20). 
 
2.2.5 Mechanism of DAST in Fluorination of Quinols 
Even the DAST reaction in SN2 is mainstream, both retention and inversion of configuration 
about carbon-containing the hydroxyl group have been noted with DAST reactions.12 While 
inversion appears unfavorable for steric reasons, the retention is observed.13 Quinol is typically 
impossible to undergo SN2 addition, so we proposed two possible mechanisms intermolecular and 
intramolecular to explain our result. In the intermolecular mechanism, DAST and quinol would 
process an SN1 addition to form para-substituted quinol. Next, DAST may active hydroxyl of 
quinol to have deoxofluorination and leave quinol to have a cation. At the same time, fluorine as a 
weak nucleophile attacked cation’s resonance structure to generate fluorination products (Scheme 
2.2). 
 




 Otherwise, in the intramolecular mechanism, after DAST activated the quinol to form the new 
complex, one fluorine transferred to para position and removed the hydroxyl group with the residue 
of DAST (Scheme 2.3). When we assumed carbon cation only existed in the intermolecular 
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process and not in the intramolecular process, there would be two types of results if we introduced 
extra halogenated source. When extra fluoride was added, the rate of the fluorinated product was 
likely to increase; when another halogenated source was added, the reaction probably generated a 
new corresponding halogenated product. The findings of Table 2.6 suggested that introducing 
extra fluoride sources failed to raise up the rate and the yield (entries1, 2 and 3). Even merely trace 
amount fluorinated product was offered when 2 equivalent TBAF was added. Turning to new 
halogenated source addition, no new halogenated product was observed by reaction with TBACl, 
TBABr, and TBAI (entries 4, 5 and 6). 
 




Table 2.6 Introduced halogen sources to DAST reaction 
Entry Halogen Source Equiv. Result a 
1 TBAF 10% 30% 
2 TBAF 1 10% 
3 TBAF 2 Trace 
4 TBACl 1 No new co-product 
5 TBABr 1 No new co-product 
6 TBAI 1 No new co-product 




In summary, following chlorination of quinol strategy, we have demonstrated an unexpected 
deoxofluorination of quinol mediated by DAST. Since the difference of nucleophilic ability 
between chlorine and flourine, deoxofluorination of quinol generated fluorinated 
cyclohexadienone, instead of para-phenol. Most of quinols can use this new path to generate 
fluorinated quinols, however, the electron withdrawing substitute quinols can offer more stable 
products than other quinols structure. With fluorinated cyclohexadienone in hand, our next targets 
are 1) increase yield and stability of all cyclohexadienone structures 2) develop a directly path to 
approach fluorinated phenol basing on this strategy. As one mild and simple way to approach 
fluorinated cyclohexadienone, which can be an important middle structure in organic synthesis, it 
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Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were 
purchased from commercial sources or synthesized using literature methods. 1H and 13C NMR 
spectra were recorded on BRUKE 500 MHz spectrometers; 1H and 13C NMR chemical shifts (δ 
values) were reported in ppm from downfield using internal standard TMS (1H NMR) or CDCl3 
(13C NMR), respectively. All mass spectra were run by the Hunter College Mass Spectrometry 
Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All infrared spectra 
were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography was performed 
over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling constants (J) are 
reported in units of hertz (Hz). The following abbreviations are used to describe multiplets: s 
(singlet), d (doublet), t (triplet), q (quartet), quint (quintuplet), sept (septet), m (multiplet), br 
(broad).  
 
Preparation of Quinols 
Quinols are made from the oxidation of phenols by phenyliodoso diacetate (PIDA) following 
general procedures of and verified by 1H and 13C NMR. 
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2.1a: quinol 2.1 (1 mmol, 124 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 1 hour. The reaction was then quenched with water (2ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 65 
mg, 30%. 
1H NMR (500 MHz, CDCl3) δ 6.94 (q, J=5 Hz, 2 H) 6.23 (d, J=10 Hz, 2 H) 1.67 (d, J=20 Hz, 3 
H); 13C NMR (500 MHz, CDCl3) δ 184.75, 146.78, 128.52, 87.21, 25.81; 






2.2a: quinol 2.2 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 1 hour. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 58 
mg, 42% 
1H NMR (500 MHz, CDCl3) δ 6.90 (q, J=5 Hz, 2 H) 6.29 (d, J=10 Hz, 2 H) 2.00 (m, J=8 Hz, 2 H), 
0.97 (t, J=7.5 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.05, 145.75, 129.64, 90.29, 31.82, 7.69; 






2.3a: quinol 2.3 (1 mmol, 153 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 81 
mg, 53% 
1H NMR (500 MHz, CDCl3) δ 6.91 (q, J=7.5 Hz, 2 H) 6.27 (d, J=10 Hz, 2 H) 1.92 (m, J=8 Hz, 2 
H), 1.41 (t, J=7 Hz 2 H), 0.99 (t, J=7 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.05, 146.21, 






2.4a: quinol 2.4 (1 mmol, 153 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 92 
mg, 60% 
1H NMR (500 MHz, CDCl3) δ 6.78 (d, J=2 Hz 1 H), 6.72 (d, J=1 Hz, 1 H), 6.71(s, J=1 Hz, 1 H), 
3.08 (m, J=1.5 Hz 1 H), 1.16(d, J=9 Hz 3 H); 13C NMR (500 MHz, CDCl3) δ 188.22, 155.00, 





2.5a: quinol 2.5 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 72 
mg, 52% 
1H NMR (500 MHz, CDCl3) δ 6.89 (m, J=2.5 Hz, 1 H) 6.69 (m, J=1.5 Hz, 1 H) 6.21(d, J=1 Hz, 1 
H), 1.93 (q, J=1 Hz, 3 H), 1.64 (d, J=20 Hz 2 H); 13C NMR (500 MHz, CDCl3) δ 185.46, 146.49, 






2.6a: quinol 2.6 (1 mmol, 138 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield:70 
mg, 51% 
1H NMR (500 MHz, CDCl3) δ 6.74(q, J=7 Hz, 1 H), 5.99(d, J=1 Hz, 1 H), 5.85(d, J=1 Hz, 1 H), 
1.91(s, 3 H), 1.45(d, J=16 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 185.16, 157.27, 147.41, 128.09, 





2.7a: quinol 2.7 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79 
mg, 52% 
1H NMR (500 MHz, CDCl3) δ 6.65 (d, J=6.5 Hz, 2 H), 1.92 (s, 6 H), 1.61 (d, J=20 Hz, 3 H); 
13C 
NMR (500 MHz, CDCl3) δ 186.22, 142.61, 141.37 87.66, 86.41, 25.61, 16.30; 
19F (400 MHz, 





2.8a: quinol 2.8 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79 
mg, 52% 
1H NMR (500 MHz, CDCl3) δ 6.01 (d, J=0.5 Hz 2 H), 2.11 (s, 6 H), 1.65 (d, J=17.5 Hz 3 H); 
13C 
NMR (500 MHz, CDCl3) δ 185.10, 158.2, 126.17, 91.65, 25.04, 17.41; 






2.9a: quinol 2.9 (1 mmol, 166 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 75 
mg, 45%. 
1H NMR (500 MHz, CDCl3) δ 6.93 (q, J=7.5 Hz 1 H), 6.32 (q, J=2 Hz, 1 H), 6.12(d, J=1.5 Hz, 1 
H), 2.38 (m, J=4.5 Hz 1 H), 1.18(d, J=9 Hz 3 H), 0.73(d, J=9 Hz, 3 H); 13C NMR (500 MHz, 
CDCl3) δ 185.13, 156.98, 143.51, 130.64, 127.96, 94.78, 34.52, 17.49, 16.74, 16.40; 
19F (400 MHz, 





2.10a: quinol 2.10 (1 mmol, 152 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 79 
mg, 52%. 
1H NMR (500 MHz, CDCl3) δ 6.92 (q, J=4.5 Hz, 1 H), 6.16 (m, J= 10Hz, 1 H), 6.02 (s, 1 H), 2.90 
(m, J=3 Hz, 2 H), 2.58 (m, J=4 Hz, 1 H), 2.32 (m, J=4 Hz, 2 H ), 2.04 (m, J=3 Hz, 1 H), 1.78 (m, 
J=3 Hz, 1H); 13C NMR (500 MHz, CDCl3) δ 185.88, 162.79, 140.70, 131.00, 123.84, 93.33, 35.06, 





2.11a: quinol 2.11 (1 mmol, 164 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 83 
mg, 51%. 
1H NMR (500 MHz, CDCl3) δ 6.85(q, J=4 Hz, 1 H), 6.24(d, J=10 Hz, 1 H), 6.07(s, 1 H), 2.67(m, 
10H); 13C NMR (500 MHz, CDCl3) δ 185.81, 159.07, 146.16, 129.39, 124.01, 38.40, 32.08, 27.42, 






2.12a: quinol 2.12 (1 mmol, 164 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). 
1H NMR (500 MHz, CDCl3) δ 6.87(d, J=10 Hz, 1 H), 6.11(d, J=10 Hz, 1 H), 2.90(m, J=1.5 Hz, 1 
H), 2.73(m, J=1.5 Hz, 3H), 2.06(m, J=1 Hz, 4H); 13C NMR (500 MHz, CDCl3) δ 184.81, 164.31, 







2.13a: quinol 2.13 (1 mmol, 192 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 100 
mg, 52%. 
1H NMR (500 MHz, CDCl3) δ 6.87(m, J=6.5 Hz, 2 H), 6.27(d, J=10 Hz, 2 H), 1.85(m, J=10 Hz, 6 
H), 1.27(m, J=10 Hz, 6 H) ; 13C NMR (500 MHz, CDCl3) δ 185.26, 145.45, 129.89, 91.85, 45.82, 






2.14a: quinol 2.14 (1 mmol, 186 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 89 
mg, 48%. 
1H NMR (500 MHz, CDCl3) δ 7.44(m, J=6.5 Hz, 5 H), 6.96(q, J=6 Hz, 2 H), 6.32(d, J=8.5, 2 H); 
13C NMR (500 MHz, CDCl3) δ 185.08, 145.70, 136.75, 129.10, 128.24, 124.78, 89.47; 
19F (400 





2.15a: quinol 2.15 (1 mmol, 265 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 148 
mg, 56%. 
1H NMR (500 MHz, CDCl3) δ 7.56(d, J=7 Hz, 2 H), 7.29(t, J=7 Hz, 2 H), 6.92(q, J=7 Hz, 2 H), 
6.33(d, J=10 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 184.75, 145.04, 135.90, 132.29, 128.53, 





2.16a: quinol 2.16 (1 mmol, 211 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 4 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 202 
mg, 96%. 
1H NMR (500 MHz, CDCl3) δ 7.75(d, J=7 Hz, 2 H), 7.55(d, J=7.5 Hz, 2 H), 6.92(q, J=7 Hz, 2 H), 
6.40(d, J=10 Hz, 2 H); 13C NMR (500 MHz, CDCl3) δ 184.43, 144.27, 141.91, 132.94, 129.12, 




methyl 2-(1-fluoro-4-oxocyclohexa-2,5-dienyl) acetate 
2.17a: quinol 2.17 (1 mmol, 182 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 6 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 160 
mg, 88%. 
1H NMR (500 MHz, CDCl3) δ 7.06(q, J=6.6 Hz, 2 H), 6.26(t, J=8Hz, 2 H), 3.69(s, 3 H), 2.91(d, 
J=18Hz, 2 H); 13C NMR (500MHz, CDCl3) δ 184.31, 167.70, 144.29, 129.67, 86.24, 77.27, 52.26, 





2.18a: quinol 2.18 (1 mmol, 166 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 
0.17 ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 6 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 116 
mg, 70%. 
1H NMR (500 MHz, CDCl3) δ 7.00(q, J=10 Hz, 2 H), 6.20(d, J=10 Hz, 1 H), 2.92(d, J=20 Hz, 2 
H), 2.19(s, 3 H); 13C NMR (500 MHz, CDCl3) δ 202.64, 184.58, 144.30, 129.46, 86.91, 85.59, 





2.19a: quinol 2.19 (1 mmol, 158 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 80 
mg, 51%. 
1H NMR (500 MHz, CDCl3) δ 6.99(q, J=10 Hz, 1 H), 6.45(s, 1 H), 6.27(d, J=10 Hz, 1 H), 1.79(d, 
J=11 Hz, 3 H); 13C NMR (500 MHz, CDCl3) δ 183.32, 153.87, 145.95, 128.16, 127.77, 88.11, 





2.20a: quinol 2.20 (1 mmol, 201 mg) was dissolved in DCM (3 ml) at 0 °C. DAST (1.2 mmol, 0.17 
ml) was injected slowly. After the addition of DAST, the reaction mixture was stirred at this 
temperature for 2 hours. The reaction was then quenched with water (2 ml) and the solvent was 
extracted with DCM (3*2 ml) then dried over Na2SO4. After filtration, then extract was 
concentrated, and the residue was purified by chromatography (EtOAc/Hexane 1/10). Yield: 140 
mg, 70%. 
1H NMR (500 MHz, CDCl3) δ 7.19 (s, 1 H), 6.86 (m, J=7.2 Hz, 1 H), 6.20 (t, J=8 Hz, 1 H), 1.46 
(s, 3 H); 3C NMR (500 MHz, CDCl3) δ 172.34, 141.78, 121.85, 120.07, 83.82, 20. 18; 
19F (400 
































































Chapter 3 Study of Total Synthesis of Anticancer Agent 
Strongylophorine-26 
3.1 Introduction of Strongylophorine Family 
The discovery of natural marine products increased significantly in previous years.1 Sponges, 
as filter-feeding marine invertebrates, host a variety of microorganisms not only reflect the 
microbial communities present in surrounding seawater but also appear to constitute a more 
specialized association between sponge hosts and microbial associates.2,3 Irrespective of the nature 
of sponge-fungi associations, sponge-derived fungal cultures has repeatedly been shown to be 
interesting sources of new bioactive secondary metabolites previously unknown from terrestrial 
strains of the same species.4 In 1978, three novel meroditerpenoids, strongylophorine‐1, 2, 3 have 
been isolated from the sponge Strongylophora durissima from Papua New Guinea by Braekman.5 
After that, people found many other members of strongylophorine family from sponges.6 The 
strongylophorines are a family of meroditerpenoids which are a terpenoid subclass delivered from 
hybrid biosynthetic pathways that fuse terpene substructures with polyketide or alkaloid 
components.7 Studies of strongylophorines prove meroditerpenoid display potency of molecular 
pharmacology and diverse biological activity.8 Strongylophorine-2, -3, -8 are inhibitors to HIF-1 
and -8 also owns neuroprotective effects; strongylophorine-26 (STP-26) is an inhibitor of tumor 
cell invasion.  
Tumor growth and metastasis cause tumor cells to invade surrounding tissues. In the invading 
process, activated vascular endothelial cells and generated new capillaries to irrigate tumors and 
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provide conduits for metastatic spread.9 A fundamental aspect of invasion and angiogenesis in cell 
migration, which is a dynamic process that involves regulated cyclical changes in cell shape, cell 
adhesion, and the cytoskeleton.10, 11 Rho-GTPases are important regulators involved in tumor 
invasion and angiogenesis.12, 13, 14 Rho, a subgroup of the Rho-GTPases, inducing the formation of 
stress fibers and mature focal adhesions, are overexpressed in some invasive cancers.15 
Strongylophorine-26 induced a decrease in actin stress fibers to cause a transient activation of the 
GTPase Rho and was treatment with the Rho inhibitor abrogated the invasive activity.16 
 




3.1 3.2 3.3 






3.2 Synthesis of Strongylophorine 
Even strongylophorines family has special latent power in pharmaceutical research, the 
challenge structure and unclarified biological activities limited the synthesis of this family. The 
syntheses of the strongylophorines have been rarely reported. Poulsen’s group first reported semi 
synthesis of strongylophorine-2 in 2016 and they developed a catalytic oxidative quinone 
heterofunctionalization method to finish strongylophorine-26 in 2018. Recently, Dethe and Sau 
published a new method for synthesis of Strongylophorines 2 and 9.  
3.2.1 Professor Poulsen Strategy Toward Strongylophorine-217 
  Poulsen’s group reported a concise route to the Strongylophorines (Scheme 3.1). The key steps 
are novel iron (III)-mediated rearrangement–cyclization cascade and a directed photochemical sp3 
C-H δ-lactonization. They were aware of the potential power semisynthetic method starting from 
labdane diterpene isocupressic acid 3.5 which was a major constituent of the bark and needles of 
the Ponderosa pine tree. Isocupressic acid 3.5 linked with the desired 4-methoxylphenol to offer 
corresponding allyl ether derivative 3.6. The cascade transformation through the exposure of allyl 
ether 3.6 to Lewis acid FeCl3 was able to generate benzyl-protected STR-1 3.7. Debenzylation of 
3.7 delivered STR-1 3.1 and then conversed to amide 3.8. Based on Barton photochemical 
lactonization, amide 3.8 closed lactone bridge and accessed provided 1, 2-Didehydro-STR-9 3.9. 
Diastereoselective hydrogenation of 3.9 under heterogeneous conditions proceeded STP-9 3.10. 
Moreover, demethylation of STR-9 3.10 could offer STR-2 3.2. 
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3.10 (STP-9)  3.2 (STP-2) 
 
ADDP=1,1’-(Azodicarbonyl)-dipiperidine, HATU=1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b] 
pyridinium 3-oxid hexafluorophosphate, HOAt=1-Hydroxy-7-azabenzotriazole, LTA=Lead(IV)acetate, 
TMS=trimethylsilyl 
 
3.2.2 Synthesis of Strongylophorine-26 by Catalytic Oxidative Quinone Method18 
  Based on previously successful synthesis of strongylophorine-2, Poulsen’s group discussed the 
conversion of 3.2 (STR-2) to 3.4 (STR-26) by C6-methoxylation. In their path, to prepare 3.4 from 
3.2, oxidative opening of the 4’-phenoxy-chromane ring and installation of the methoxy 
substituent are required. However, the p-benzoquione 3.11 can be easily generated, there was a 
lack of a general method for methoxylation of the p-benzoquione. Inspired by the method for the 
aerobic coupling of phenols to o-quinones of Lumb and the evaluation of other methods,19-21 





Scheme 3.2 Mechanism of p-benzoquinone methoxylation 
 
 






3.2 (STR-2)  3.11 
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  3.4  
 
 
  3.12 
3.4/3.12=1.3/1  
Total 61% in two steps 
 
  Following their method for the functionalization of p-quinones, they constructed a path of 3.4 
with Chromane-oxidation of 3.2 using NaIO4·SiO2 afforded the quinone 3.11. Immediately 
subjected 3.11 to methoxylation conditions using Co(OAc)2 in methanol at reflux for 44 hours. 
These two steps reaction could generate a mixture of 3.4 and the tentative 5’-regioisomer (3.12) in 
61% yield (Scheme 3.3).  
 
3.2.3 Dethe and Sau’s Strategy Toward Strongylophorine-2 and 922 
  Recently, Dethe and Sau published their total synthesis work of Strongylophorines -2 (3.2) and 
-9 (3.10) (Scheme 3.4). Their work began with selective ketalization and alkylation of the Wieland-
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Miescher ketone derivative 3.13 to generate alkylated product 3.14. In the first key step, 3.14 
successfully constructed the tricyclic terpenoid building block enone 3.15 by Robinson 
annulation.23 Following a few steps of functional groups interconversion, enone 3.15 transferred 
to tricyclic alcohol 3.19. The next step was another key element in the route, and they employed 
Suarez photocatalysis condition using PI(OAc)2/I2 for sp
3 C-H activation on the axial methyl of 
3.19.24 Since the product of Suarez photocatalysis was unstable, directly following by Pinnick 
oxidation and TBAF mediated lactonization on the intermedia offered requisite lactone 3.20. 
Replacement of the enone at the -OTBS position of 3.20 using deprotection, 1-C Witting 
olefination, and allylic oxidation could offer enone 3.22. With the required aromatic fragment 3.27 
and the terpene enone 3.22 in hand, two parts were coupled to generate Michael adduct 3.23. To 
incorporate the remaining group in the terpene part, the ketone was covered to an exomethylene 
by Witting olefination to produce 3.24. After debenzylation and cyclization, 3.24 transferred to 
3.10 (STP-9), which could convert to 3.2 (STP-2) by demethylation. 
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3.15  3.16  
 
 
3.17  3.18  
 
 






3.21  3.22  
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3.23  3.24  
 
 
3.25   
 
3.10 (STP-9)   3.2 (STP-2) 
 
 
3.26 3.27   
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3.3 Study of Total Synthesis of Anticancer Agent Strongylophorine-26 
3.3.1 Brief Route to Strongylophorine-26 
The route benefits from the use of known tricyclic precursors, and a highly convergent plan in 
which advanced tetracyclic and quinone precursors are coupled at a late stage (Scheme 3.5). 
Precursor 3.28 is followed by Snider radical cyclization to close tricyclic ring, then following 
mCPBA epoxidation to generate precursor 3.29.25 Selective strategy can open epoxy ring of 3.29 
to approach diol product which would be protected by 2-methoxyprop-1-ene to afford 3.30.26 
Further reducing ketone on the tricyclic ring with NaBH4 and introducing ammonia could form 
amide 3.31. Remote C-H functionalization in 3.31 could be affected to afford 3.32 by Barton’s N-
iodoamide method.27 Conversion of the primary alcohol 3.32 to the halide fragment then followed 
by Negishi coupling would provide 3.33.28 Debenzylation followed by DDQ oxidation would 
afford STP-26 3.4. 
 


















 3.4  
 
3.3.2 Synthesis of precursor 3.28 from Farnesol 3.34 



















3.39  3.29  
 
   
3.40    
 
The synthesis commenced with preparing the precursor 3.28 (Scheme 3.6). Our synthetic 
sequence began with natural 15-carbon acyclic sesquiterpene alcohol Farnesol 3.34, which was 
protected by acetic anhydride to offer farnesyl acetate 3.35. Farnesyl acetate 3.35 was subjected to 
the conditions for Sharpless oxidation to approach allylic alcohol 3.36. Upon treatment with 
lithium bromide, allylic alcohol 3.36 could provide bromide 3.37 in good yield 83%. Exposure of 
189
3.37 to 3.41, sodium hydride, and n-Butyllithium, resulted in diterpenoid 3.38. Diterpenoid 3.38 
could also be protected by acetic anhydride to generate precursor 3.28. We employed the Mn-Cu-
catalyzed cascade radical reaction developed by Snider to prepare tricyclic dieterpenoid 3.39. In 
our opinion, by using mCPBA or DMSO oxidation reagent, epoxide 3.40 will be in hand.  
 
3.3.3 The study of Sharpless Oxidation 
Exposed olefin with selenium dioxide would approach allylic alcohols. However, the main 
weakness of this oxidation method is SeO2 is a high toxic reagent. Following Sharpless’s study 
mixed olefins with tert-Butyl hydroperoxide in the presence of catalytic (1.5-2%) SeO2, would 
produce allylic alcohols in yields comparable with, or better than, those obtained with 
stoichiometric SeO2 alone.
29 Another problem with this approach is that it fails to long-chain 
olefins. It had been observed long-chain olefins only generated 20% or lower yield allylic alcohol. 
A significant reason for the low yield was that selective reactivity of SeO2 was reduced due to a 
longer alkyl chain length.30 Shibuya demonstrated that the replacement of salicylic acid with 
formic acid led to offer allyl formate in high yield.31 Kitagawa et al. reported without salicylic acid 
and shorting reaction time could increase allylic alcohol productivity in Sharpless reaction.32 
However, those theories did not fully resolve the low activity of long-chain olefins. We wished to 
have an opportunity to modify the Sharpless strategy for long-chain olefin by avoiding the use of 
excess SeO2 and reducing side products like aldehyde, to convert the farnesyl acetate to the desired 
allylic substituent (Table 3.1). 
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Table 3.1 Modify of Sharpless reaction  
Entry SeO2 Solvent T (
oC) Additive a Yield (%) c 




















6 2 Dioxane 60 Formic acidb  None 
a. Entry 1 to 5, tBuOOH (2.5 equiv.) and salicylic acid (10 mol%) were added. b. Formic acid (2 equiv.) was 
employed. c Isolated yields. 
191
Oxidation of farnesyl acetate 3.34 with SeO2 in the presence of tert-Butyl hydroperoxide readily 
yield allylic alcohol 3.35 in 41%. Application of commonly used Sharpless oxidation condition, 
which involved SeO2 reactivity decrease, and side over-oxidation aldehyde product, resulted in 
very slow oxidation of 3.34 providing low yields of 18%. Attempt to optimize this reaction by 
Shibuya condition was not successful (entry 6). Similarly, merely little improvement in yield (2%) 
was observed when salicylic acid was removed as described in an alternative procedure by 
Kitagawa.  




Table 3.2 Temperature and reaction time relationship for Sharpless oxidationa 
Temperature=25 °C 
Entry Time (h) Yield (%) b Recycled Farnesyl acetate (%) c 
1 2 18 36 
3 4 18 36 
3 8 12 34 
Temperature=0 °C 
4 2 Trace 90 
5 4 12 80 
6 8 21 66 
a. SeO2 (1 mol%), tBuOOH (2.5 equiv.), and salicylic acid (10 mol%) were employed in Sharpless oxidation. b. 
c Isolated yields. 
To improve the reactivity of the Sharpless procedure, we sought to figure out the best reaction 
conditions. Except for dichloromethane and dichloroethane, other solvents could not offer cheerful 
results. Production of allylic alcohol 3.35 peaked at 2 hours, after that the graph showed that there 
had been a steady decline. Moreover, at 0 °C oxidation process was slower, and the continual 
growth of 3.35 arrived maximum yield at 8 hours. Both room temperature (25 °C) and 0 °C shared 
similar yield, but 0 °C is different from room temperature (25 °C) in the generation of less aldehyde 
(Scheme 3.8 and Table 3.2). In the case of Sharpless oxidation, merely depending on adjusting 
reaction temperature and time resulted in little improvement in yield. To overcome activity 
decreasing of SeO2, we proposed an extra addition of SeO2 can optimize oxidation (Table 3.3). 
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Although the extra addition of SeO2 probably rises the formation of side products, aldehyde level 
can remain steady with low reaction temperature. The yield of the desired product sharply 
increased with an extra SeO2 addition and rose to a high point and peaked in 10% SeO2. However, 
with more addition of SeO2, the yield marked decrease, 16% yield with 20% SeO2 and trace yield 
with 30% SeO2.   
 
Table 3.3 Difference of SeO2 using in Sharpless oxidation a 
Entry SeO2 (mol%) Yield (%) 
b Recovered Farnesyl acetate (%) c 
1 1 22 66 
2 10 37 34 
3 20 16 34 
4 30 12 0 
a. tBuOOH (2.5 equiv.), and salicylic acid (10 mol%) were employed. b. c Isolated yields. 
 
 Compared to original literature precedent for the Sharpless reaction, although the excess 
amount of SeO2 would boost over oxidation products, the reaction could set up under an ice bath 
(0 °C) condition and extend reaction time to 8 hours. With 10% SeO2 in dichloromethane, isolated 
allylic alcohol yield can arrive at 37% and recycled farnesyl acetate at 34%. 
3.3.4 Conclusion  
  In conclusion, opening the epoxide ring of 3.29 is the next step and it would offer diol structure. 
Because of the stereospecificity of diol, selecting the right path is a challenge. However, this long-
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lasting effort gave us the occasion of developing new relevant methodologies of synthesis. The 
study of the Sharpless oxidation strategy allows us to optimize conditions for complex starting 
materials. The new synthetic application for all strongylophorine-26 is currently pursued in our 
laboratory and will be reported in due course. 
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Supporting information  
General Consideration 
Anhydrous CH2Cl2 was distilled from CaH2 under an atmosphere of argon. All reagents were 
purchased from commercial sources or synthesized using literature methods. 1H and 13C NMR 
spectra were recorded on BRUKE 500 MHz spectrometers; 1H and 13C NMR chemical shifts (δ 
values) were reported in ppm from downfield using internal standard TMS (1H NMR) or CDCl3 
(13C NMR), respectively. All mass spectra were run by the Hunter College Mass Spectrometry 
Facility and taken on an Agilent 6520A Q-TOF using electrospray ionization. All infrared spectra 
were taken on a Thermo Nicolet IR100 spectrometer. Column chromatography was performed 
over silica with a porosity of 60 Å and a particle size of 40-63 µm. Coupling constants (J) are 
reported in units of hertz (Hz). The following abbreviations are used to describe multiplets: s 




3.35 (2E,6Z)-3,7,11-trimethyldodeca-2,6,10-trienyl acetate 
25 g 3.34 was dissolved in 40 ml dry pyridine, then slowly added 40 ml Ac2O in four potions over 
200
a 15 min period. The mixture was stirred for 6h after that poured the mixture into 250 g ice. Added 
400ml water, extracted with five 100ml portions of hexane. The organic layer washed with 2*50 
ml water, 5% sulfuric acid and saturated NaHCO3 solution. Drying by Na2SO4. The compound 
3.35 is yellow oil. 
Yield: 96% (30.3 g) 1HNMR: δ=5.38 (t, J=7.1 Hz, 1 H), 5.12 (d, J=4.4 Hz, 2 H), 4.61 (d, J=7.1 Hz, 
2 H), 2.19 (m, 11 H), 1.72 (d, J=, 13 Hz, 6 H), 1.62 (s, 6 H) ppm; 13CNMR: δ=171.20, 142.35, 
135.49, 131.37, 124.30, 123.61, 118.21, 61.43, 39.70, 26.71, 26.17, 25.72, 21.10, 17.71, 16.49, 
16.03 ppm. HRMS m/z calculated for C17H28O2 [M+H
+] 265.2123, found 265.2149. 
 
 
3.36 (2E,6Z,10E)-12-hydroxy-3,7,11-trimethyldodeca-2,6,10-trienyl acetate 
SeO2 (0.26 g, 0.23 mmol), 40 ml CH2Cl2 and 6.8 ml 90% tert-Butyl hydroperoxide was mixed and 
stirred under room temperature (25 oC) for half hour, and then transferred the mixture into ice bath 
(0 °C) condition. 3.35 (6 g, 22.7 mmol) was introduced into the mixture solution in 20 min and the 
whole mixture was stirred in the ice bath (0 °C) for 8 h. The reaction was quenched by saturated 
20 ml Na2S2O3 solution, then extracted by 3*10 ml CH2Cl2, washed by saturated NaHCO3 solution 
and dried by Na2SO4. The compound 3.36 is yellow oil. 
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Yield: 37% (2.4 g) 1HNMR: δ=5.39 (m, J=1 Hz, 2 H), 5.11 (t, J=6.5 Hz, 1 H), 4.59 (d, J=7 Hz, 2 
H), 3.99 (s, 1 H), 2.12 (m, 10 H), 1.70 (m, 11 H), 1.26 (s, 1 H) ppm; 13CNMR: δ=171.24, 142.26, 
135.11, 134.74, 125.99, 123.91, 118.27, 69.02, 61.43, 39.49, 39.26, 26.15, 26.12, 25.75, 21.10, 
16.49, 16.02, 13.72 ppm. HRMS m/z calculated for C17H28O3 [M+H
+] 281.2072, found 281.2064. 
 
 
3.37 (2E,6Z,10E)-12-bromo-3,7,11-trimethyldodeca-2,6,10-trienyl acetate 
3.36 (7.6 g, 27 mmol) was dissolved in 120 ml dry THF and introduced the flask under the 
acetonitrile dry ice bath (-46 °C). MsCl (methane sulfonyl chloride, 4.0 g, 2.73 ml, 35 mmol) and 
triethylamine (5.5 g, 7.52 ml, 54 mmol) were added over 5 min, and the solution would be stirred 
in a cold bath for 45 min. Dropwise added LiBr (9.4 g, 108 mmol) in 20ml THF solution into the 
mixture of 3.36, then stirred for 1 h. The reaction was quenched by 200 ml cold water and extracted 
by 4*60 ml ethyl ether. The organic layer was dried by Na2SO4. The compound 3.37 is yellow oil. 
Yield: 83% (7.7 g) 1HNMR:δ=5.51 (t, J=7 Hz, 1 H), 5.28 (t, J=7 Hz, 1 H), 5.04(t, J=5.5 Hz, 2 H), 
4.52 (d, J=7 Hz, 2 H), 2.05 (m, 11 H), 1.68 (m, 10 H) ppm; 13CNMR: δ=171.20, 142.23, 134.68, 
131.20, 124.24, 118.27, 61.42, 41.92, 39.46, 38.74, 26.82, 26.14, 21.11, 16.49, 15.99, 14.68 ppm. 
HRMS m/z calculated for C17H27BrO2 [M+H




3.38 (6E,10Z,14E)-ethyl 16-hydroxy-2,6,10,14-tetramethyl-3-oxohexadeca-6,10,14-trienoate 
Ethyl 2-methyl-3-oxobutanoate 3.40 (7.84 g, 54.5 mmol) was added via a syringe to a suspension 
of NaH (2.4 g, 54.4 mol) and HMPA (2 ml) in 120 ml dry THF at 0 oC under N2 protection with 
stirring over 45 min. After addition, the reaction became viscous, then added another 2 ml HMPA 
and 80 ml THF and stirring were continued for 1 h. 22 ml n-Butyllithium in hexane was added 
dropwise by syringe over 1 h and continued to be stirring for 1 h at 0 oC. Dissolved 3.37 (4.67 g, 
13.6 mmol) in 20 ml THF and dropwise added into the flask over 30 min and stirring another 1 h. 
50 ml 10% HCl solution was added to quench the reaction and followed by addition of 30 ml 
CH2Cl2. The organic layer was washed with 100 ml water and 100 ml brine, dried by Na2SO4. The 
compound 3.38 is yellow oil. 
Yield: 88% (4.4 g) 1HNMR:δ=5.45 (t, J=7 Hz, 1 H), 5.13 (d, J=6.5 Hz, 2 H), 4.23 (m, J=7 Hz, 4 
H), 3.56 (m, J=7 Hz, 1 H), 2.71 (m, J=7.5 Hz, 2 H), 2.14 (t, 7,5 Hz, 2 H), 2.08 (m, J=7 Hz, 8 H), 
1.70 (s, 3 H), 1.61 (s, 5 H), 1.35 (d, J=7 Hz, 3 H), 1.30 (t, J=7.5 Hz, 3 H) ppm; 13CNMR: δ=205.73, 
170.63, 139.72, 135.16, 133.33, 125.02, 123.39, 123.36, 61.38, 59.42, 52.91, 40.19, 39.63, 33.30, 
30.48, 26.92, 25.90, 16.30, 14.11, 12.18 ppm. HRMS m/z calculated for C22H36O4 [M+H
+] 
203
365.2647, found 365.2661. 
 
 
3.28 (6E,10E,14E)-ethyl 16-acetoxy-2,6,10,14-tetramethyl-3-oxohexadeca-6,10,14-trienoate 
3.38 (3 g, 8 mmol) was dissolved in 4 ml dry pyridine, then slowly added 1.5 ml Ac2O in four 
potions over a 15 min period. The mixture was stirred for 6 h after that poured the mixture into 30 
g ice. Added 60 ml water, extracted with five 30 ml portions of hexane. The organic layer washed 
with 2*10 ml water, 5% sulfuric acid and saturated NaHCO3 solution. Drying by Na2SO4. The 
compound 3.28 is yellow oil. 
Yield: 92% (3 g) 1HNMR: δ=5.42 (t, J=7 Hz, 1 H), 5.11 (q, J=6.5 Hz, 2 H), 4.20 (q, J=7.5 Hz, 2 
H), 4.16 (d, J=7.5 Hz, 2 H), 3.53 (q, J=7 Hz, 1 H), 2.68 (m, J=7.5 Hz, 2 H), 2.26 (t, J=8 Hz, 2 H), 
2.11 (m, 8 H), 1.67 (s, 3 H), 1.58 (s, 5 H), 1.33 (d, J=7 Hz, 3 H), 1.26 (t, J=7 Hz, 5H) ppm; 13CNMR: 
δ=205.73, 170.63, 139.73, 135.16, 133.33, 125.02, 123.93, 123.36, 61.35, 59.42, 52.91, 40.16, 
39.53, 33.30, 29.72, 26.56, 26.26, 16.30, 16.06, 14.12, 12.81, 12.78 ppm. HRMS m/z calculated 
for C24H38O5 [M+H







Methanol (10 ml) poured into 100 ml round bottom flask and bubbled by nitrogen for 30min to 
exile oxygen. Mn(OAc)32H2O (1.4 g, 4.93 mmol) and Cu(OAc)2H2O (502 mg, 2.46 mmol) was 
dissolved in Methanol and kept stirring for 10min. Dissolved 3.28 (1 g, 2.46 mmol) in 15 ml 
methanol and dropwise added into the flask over 30 min and stirring another 4 h. Open to the air 
to quench the reaction and the organic layer was washed with 20 ml water then flowed by 3*15 ml 
CH2Cl2 and 10 ml brine, Dried by Na2SO4. The compound 3.29 is yellow oil. 
Yield: 21% (210 mg) 1HNRM: δ=7.09 (d, J=1 Hz, 1 H), 7.055(d, J=8 Hz, 1 H), 4.19 (m, J=3.5 Hz, 
2 H), 3.03 (m, J=6.5 Hz, 1 H), 2.81 (dd, J=6 Hz, J=6.5 Hz, 1 H), 2.47 (m, J=1.5 Hz, 2 H), 2.19 (m, 
J=4 Hz, 3 H), 1.87 (m, J=3.5 Hz, 2 H), 1.81 (m, J=7 Hz, 1 H), 1.78 (q, J=7 Hz, 2 H), 1.66 (m. 14 
H), 1.05 (s, 3 H) ppm; 13CNMR: δ=208.51, 173.56, 136.94, 136.76, 135.15, 119.46, 61.07, 57.81, 
57.57, 54.96, 40.60, 40.58, 37.60, 36.47, 33.99, 25.76, 20.90, 20.61, 20.54, 18.76, 13.93, 13.68 
ppm. HRMS m/z calculated for C24H36O5 [M+H
+] 405.2596, found 405.2610. 
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